The groundbreaking rise of Viagra has firmly established as a benchmark of pharmaceutical success, however its future within the broader market now presents questions about long-term returns . Alternative versions are undercutting patent protection , leading to anxieties that supporting companies significantly dependent to Viagra's once-dominant in